Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-03-04
1999-10-19
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548251, 548557, 548577, 560205, 564104, 564106, 564204, 564209, 570127, 570184, A61K 3141, C07D25706
Patent
active
059689633
ABSTRACT:
Certain compounds have been synthesized and found to be effective inhibitors of phospholipase A.sub.2 (PLA.sub.2), and thereby useful in the treatment of intestinal cholesterol absorption and the disease states arising therefrom, such as hypercholesterolemia and coronary artery disease.
REFERENCES:
patent: 3573290 (1971-03-01), Sallmann et al.
patent: 4161529 (1979-07-01), Beregi et al.
"Alkylation Studies with Aminotetrazoles", K. Wilson, R. Herbst and Willard Haak, J. Org. Chem., 24 (1046-51); 1959.
"Synthesis of Iminotetrazoline Derivatives as Trichomonacidal and Fungicidal Agents," Robert Herbst and Charles F. Froberger, J. Org. Chem. 22(1050-1053); 1957.
"Alkylated 5-Aminotetrazoles, Their Preparation and Properties", Douglas F. Percival and Robert M. Herbst, J. Org. Chem. 22 (925-33); 1957.
J. Lipid Res., vol. 22, pp. 744-752 (1981), Rampone et al.
Lipids, vol. 15, pp. 395-400 (1980), Hollander et al.
J. Lipid Res., vol. 21, pp. 525-536 (1980), Beil et al.
Biochim. Biophys. Acta, vol. 486, pp. 500-510 (1977), Rampone et al.
Digestive Diseases, vol. 23, pp. 316-320 (1978), O'Connor et al.
J. Lipid Res., vol. 34, pp. 377-395 (1993), Harwood et al.
Arch Intern Med., vol. 153, pp. 1345-1353 (1993), Dressman et al.
Atherosclerosis VIII, pp. 791-794 (1989), Kesaniemi et al.
Biochemistry, vol. 30, No. 42, pp. 10256-10268 (1991), Jain et al.
J. Med. Chem., vol. 35, No. 19, pp. 3584-3586 (1992), Jain et al.
PCT International Search Report, PCT/US 95/08167.
Grogan, et al., J. Pharm. Sci., vol. 61, No. 6, 1972, pp. 802-803.
Ashbrook Charles W.
Oswecki Jane C.
Richter Johann
Warner-Lambert & Company
LandOfFree
PLA.sub.2 inhibitors and their use for inhibition of intestinal does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PLA.sub.2 inhibitors and their use for inhibition of intestinal , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PLA.sub.2 inhibitors and their use for inhibition of intestinal will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2055848